Lifebit (Biotechnology) Overview
- Founded
- 2017
- Status
- Private
- Employees
- 64
- Latest Deal Type
- Series B
- Latest Deal Amount
- $60.2M
- Investors
- 10
Lifebit (Biotechnology) General Information
Description
Developer of genomics and bioinformatics platform designed to unified research over democratizing access to omics data. The company's platform offers reproducible and easy-to-share genomics analysis in a single click provides integration with free open-source analysis alongside a marketplace of proprietary alternatives and gives access to visualization of large data sets associated with human genome sequencing, enabling researchers to run complex analyses and generate meaningful insights and secure research over distributed big data.
Contact Information
Website
www.lifebit.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Database Software
Primary Office
- 9 Appold Street
- Hackney
- London EC2A 2AP
- England, United Kingdom
Lifebit (Biotechnology) Timeline
Lifebit (Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series B) | 21-Sep-2021 | $60.2M | 000.00 | 00000 | Completed | Generating Revenue |
| 4. Early Stage VC (Series A) | 30-Apr-2020 | 00.000 | 000.00 | 0000 | Completed | Generating Revenue |
| 3. Grant | 01-Jan-2019 | 000.00 | 00.000 | Completed | Generating Revenue | |
| 2. Seed Round | 19-Jul-2018 | $3.27M | $3.29M | 00.00 | Completed | Generating Revenue |
| 1. Accelerator/Incubator | 01-Jul-2017 | $20K | $20K | 00000 | Completed | Startup |
Lifebit (Biotechnology) Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| B Preferred | 000,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 | |
| A Preferred | 000,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 | |
| A Ordinary | 00,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.000 | |
| Seed | 000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00.000 | ||
| A Ordinary | 18,339 | $0.000138 | $7.14 | $7.14 | 1x | $7.14 | 0.87% | |
| Ordinary | 72,420 | $0.000138 | $0.28 | $0.28 | 1x | $0.28 | 3.43% |
Lifebit (Biotechnology) Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of genomics and bioinformatics platform designed to unified research over democratizing access to omics data.
Biotechnology
London, United Kingdom
64
As of 2021
000.00
0000
0000-00-00
00000000000
000.00
00000 00
strud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in
00000000 00000000
London, United Kingdom
00
As of 0000
0000
00.00
0000-00-00
00000000000
0000
00000000
t, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis
000000000 00000 (0000000000)
Mountain View, CA
000
As of 0000
00000
0000
0000-00-00
00000000000
00000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialLifebit (Biotechnology) Competitors (21)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Eagle Genomics | Venture Capital-Backed | London, United Kingdom | 00 | 0000 | 00000000000 | 0000 |
| 00000000 | Venture Capital-Backed | Mountain View, CA | 000 | 00000 | 00000000000 | 00000 |
| 00000000 (00000000 | Venture Capital-Backed | San Diego, CA | 00 | 00.000 | 000000000 | 00.000 |
| 0000000 | Formerly VC-backed | Rijswijk, Netherlands | 00 | 000.00 | 000000&0 | 000.00 |
| 0000000 | Formerly VC-backed | Lund, Sweden | 00 | 000.00 | 00000000 | 000.00 |
Lifebit (Biotechnology) Patents
Lifebit (Biotechnology) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-10769167-B1 | Federated computational analysis over distributed data | Active | 20-Dec-2019 | 000000000 | |
| US-20210158897-A1 | Bioactive compound effect and disease target predictions | Pending | 05-Apr-2019 | 000000000 |
Lifebit (Biotechnology) Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Maria Chatzou Ph.D | Co-Founder & Chief Executive Officer | ||
| Pablo Prieto Barja Ph.D | Co-Founder, Chief Technology Officer & Chief Scientific Officer |
Lifebit (Biotechnology) Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Alexander Mckinnon | Lifebit (Biotechnology) | Board Member | 000 0000 |
| Antoine Zins | Lifebit (Biotechnology) | Board Member | 000 0000 |
Lifebit (Biotechnology) Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialLifebit (Biotechnology) Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Tiger Global Management | Growth/Expansion | Minority | 000 0000 | 000000 0 | |
| Eurazeo | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| Innovate UK | Government | Minority | 000 0000 | 000000 0 | |
| Beacon Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Connect Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |